A new test promises better diagnosis of TB in children

With bacteriological diagnosis of TB (via sputum samples) in children, particularly in those aged below five years, being riddled with problems, scientists are looking at alternative methods that do not rely on sputum samples. A proof-of-concept study published recently in The New England Journal of Medicine shows promise. The sample used was blood. Suzanne T. … Continue reading A new test promises better diagnosis of TB in children

IPAQT: subsidised Xpert TB test in private labs gets popular

The number of labs/private hospitals in the country offering the WHO-approved tests like GeneXpert, Line Probe Assay (LPA) for diagnosing TB disease at a subsidised price has reached 54. There are over 10,000 collection centres spread across the country. In eight months since the novel initiative — Improving Access to Affordable & Quality TB Tests … Continue reading IPAQT: subsidised Xpert TB test in private labs gets popular

WHO-approved TB test, now at a subsidised price

Published in The Hindu on March 28, 2013 Providing accurate diagnosis for TB and thereby enabling earlier initiation of treatment has got a big boost. Currently, around 30 private laboratories across the country have come together to provide the WHO-approved GeneXpert MTB/RIF molecular test to diagnose active TB at a subsidised ceiling price of Rs.1,700 … Continue reading WHO-approved TB test, now at a subsidised price

Editorial: A necessary ban

Published in The Hindu on June 26, 2012 The recent decision by the Ministry of Health and Family Welfare to ban the manufacture, sale, distribution and use of serological (blood) test kits for diagnosing active tuberculosis — both pulmonary and extra-pulmonary — is significant. The blood test diagnoses active TB based on antibody response. The … Continue reading Editorial: A necessary ban